Nephrocare Health Services: IPO Proceeds Utilisation Report for Q2 2026

Nephrocare Health Services Ltd has submitted its Monitoring Agency Report for the quarter ended June 30, 2026, detailing the utilization of its Initial Public Offer (IPO) proceeds. The report, issued by Crisil Ratings Limited, was reviewed by the Audit Committee and taken on record by the Board of Directors. The company's IPO, which occurred from December 10-12, 2025, raised gross proceeds of ₹3,534.05 million, with net proceeds amounting to ₹3,251.53 million after deducting issue expenses of ₹282.52 million. The report confirms no deviation from the IPO's stated objects.